Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors.
Yung-Jue Bang
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Wu-Chou Su
No relevant relationships to disclose
Do-Hyun Nam
No relevant relationships to disclose
Wan-Teck Lim
Honoraria - Novartis
Todd Michael Bauer
No relevant relationships to disclose
Irene Brana
No relevant relationships to disclose
Ronnie Tung-Ping Poon
No relevant relationships to disclose
David S. Hong
Research Funding - miRNA Therapeutics
Chia-Chi Lin
No relevant relationships to disclose
Bin Peng
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Yingxi Zhang
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Sylvia Zhao
No relevant relationships to disclose
Arun Kumar
Employment or Leadership Position - Novartis
Mikhail Akimov
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Brigette Ma
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis